Sort
35,931 grants matching “parkinsons”
Mapping Synaptic Density in Prodromal and Manifest Lewy Body Dementia
$749,746Catherine L. Gallagher · University Of Wisconsin-Madison · R01 · FY2025 · AG
Regulation of human tau expression and tauopathy by alpha-synuclein
$749,496Michael K Lee · University Of Minnesota · R01 · FY2025 · AG
Wisconsin Stem Cell Research Center
$749,375Wicell Research Institute · P20 · FY2005 · GM
Wisconsin Stem Cell Research Center
$749,375Wicell Research Institute · P20 · FY2004 · GM
Dietary Modulation of Neuroinflammation in Age-Related Memory Disorders
$749,369Richard P Sloan · Columbia University Health Sciences · R01 · FY2021 · AG
Electrophysiological Probes And Treatments In Neurobehavioral Disorders
$748,823Eric M Wassermann · National Institute Of Neurological Disorders And Stroke · ZIA · FY2012 · NS
Novel Pharmacotherapy for Parkinson's Disease
$748,722Darpharma, Inc. · R44 · FY2003 · NS
Mass Spectrometry-Based Protein Footprinting: A New Tool for Amyloid Protein Aggregation
$748,641Michael L Gross · Washington University · R01 · FY2024 · AG
Human Cerebrospinal Fluid Extracellular Vesicles: Utility as Disease Specific Biomarkers and Impact on Alzheimer's Disease Pathology
$748,595Julie Anne Saugstad · Oregon Health & Science University · R01 · FY2025 · AG
Development of PET Tracer for Imaging Brain Inflammation
$748,349Vijay Sharma · Washington University · R01 · FY2024 · AG
PERSEVERE in Lewy Body Dementia: A Randomized, Controlled Trial of Peer Mentor Support and Caregiver Education
$748,170Jori Erin Fleisher · Rush University Medical Center · R01 · FY2025 · AG
Ambulatory blood pressure and falls in older treated patients with hypertension
$748,004Kristi Reynolds · Kaiser Foundation Research Institute · R01 · FY2020 · HL
Identification of Cell Type-specific EVs for Neuroscience Research
$747,646John P Nolan · Cellarcus Biosciences Inc · R44 · FY2019 · DA
Environmental and Genetic Risks for Parkinson's Disease
$747,609Stanford University · R01 · FY2002 · NS
Genetic characterization of atypical parkinsonism
$747,571Sonja Scholz · National Institute Of Neurological Disorders And Stroke · ZIA · FY2017 · NS
Bioactive lipids as effectors and indicators of the deleterious effects of environmental exposure on chronic diseases
$747,563Bruce D Hammock · University Of California At Davis · R35 · FY2020 · ES
Enabling Shared Analysis and Processing of Large Neurophysiology Data
$747,542William J Schroeder · Kitware, Inc. · R44 · FY2017 · MH
Salivary Extracellular Vesicles as Biomarkers for Alzheimer's Disease and Related Disorders
$747,279Jill Kreiling · Brown University · R01 · FY2025 · AG
Assessment of Ultrsound-facilitated Neurotherapeutics in Alzheimer's Disease
$747,265Elisa E Konofagou · Columbia University Health Sciences · R01 · FY2016 · AG
Using human brain connectivity to identify the causal neuroanatomical substrate of depression symptoms
$747,166Michael D Fox · Brigham And Women'S Hospital · R01 · FY2024 · MH
Using human brain connectivity to identify the causal neuroanatomical substrate of depression symptoms
$747,166Michael D Fox · Brigham And Women'S Hospital · R01 · FY2025 · MH
Using human brain connectivity to identify the causal neuroanatomical substrate of depression symptoms
$747,166Michael D Fox · Brigham And Women'S Hospital · R01 · FY2023 · MH
The impact of early Tau pathology on cognitive progression and neuropsychiatric symptoms in Parkinson's disease
$746,957Kathleen Lombard Poston · Stanford University · R01 · FY2021 · NS
The impact of early Tau pathology on cognitive progression and neuropsychiatric symptoms in Parkinson's disease
$746,957Kathleen Lombard Poston · Stanford University · R01 · FY2022 · NS
Mobility Rehab: A Biofeedback System for Mobility Rehabilitation for Older Adults
$746,713Mahmoud El-Gohary · Apdm, Inc. · R44 · FY2018 · AG